Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS

NCT04366115 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

ARDS
Covid19
Influenza, Human

Interventions

DRUG: AVM0703
DRUG: Placebo

Sponsor

AVM Biotechnology Inc

Collaborators

[object Object]